Damora Therapeutics Inc (DMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Operating Expenses | 17,121 | 16,939 | 13,468 | 12,939 | 12,268 |
| Operating Income | -17,121 | -16,939 | -13,468 | -12,939 | -12,268 |
| Other Income | 234 | 1 | 59 | 243 | -34 |
| Pre-tax Income | -16,887 | -16,938 | -13,409 | -12,696 | -12,302 |
| Net Income Continuous | -16,887 | -16,938 | -13,409 | -12,696 | -12,302 |
| Net Income | $-16,887 | $-16,938 | $-13,409 | $-12,696 | $-12,302 |
| EPS Basic Total Ops | -16.75 | -16.75 | -13.25 | -12.50 | -12.25 |
| EPS Basic Continuous Ops | -16.71 | -16.76 | -13.27 | -12.56 | -12.17 |
| EPS Diluted Total Ops | -16.75 | -16.75 | -13.25 | -12.50 | -12.25 |
| EPS Diluted Continuous Ops | -16.71 | -16.76 | -13.27 | -12.56 | -12.17 |
| EBITDA(a) | $-16,940 | $-16,667 | $-13,120 | $-12,434 | $-11,939 |